CYTOKINETICS INC (CYTK) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for CYTOKINETICS INC (CYTK): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 42/100 — a percentile rank of CYTOKINETICS INC’s fundamentals against Manufacturing peers, weakest on management. A quality ranking, not a price prediction.
| Market cap | $9.1B |
| P / S | 134.8× |
| EV / EBITDA | -14.4× |
| Gross margin | 92.2% |
| Operating margin | -1046.1% |
| Net margin | -1141.9% |
| Return on equity | 515.3% |
| ROIC | -98.5% |
| Revenue growth | -21.1% |
| Debt / equity | -6.6× |
| Dividend yield | 0.0% |
Is CYTOKINETICS INC overvalued? P/S looks fair vs its 5-year range.
Independent of the events above — derived from CYTOKINETICS INC’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact